HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead

Maureen van Molken; Matthijs Versteegh; Balázs Nagy; Sarah Wordsworth

doi:10.2217/pme-2022-0074

HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead

Maureen van Molken^*, Matthijs Versteegh, Balázs Nagy, Sarah Wordsworth

^*Corresponding author for this work

Health Technology Assessment (HTA)

Research output: Contribution to journal › Editorial › Academic › peer-review

60 Downloads (Pure)

Original language	English
Pages (from-to)	299-303
Number of pages	5
Journal	Personalized Medicine
Volume	20
Issue number	4
DOIs	https://doi.org/10.2217/pme-2022-0074
Publication status	E-pub ahead of print - 22 Sept 2023

Bibliographical note

Funding information:
The HEcoPerMed project has received funding from the EU’s Horizon 2020 research and innovation program under grant agreement No. 824997. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Copyright:
2023 The Authors

Access to Document

10.2217/pme-2022-0074Licence: CC BY

rutten-van-m_lken-et-al-2023-hecopermed-personalized-medicine-from-a-health-economic-perspective-lessons-learned-and.pdfFinal published version, 469 KBLicence: CC BY

Cite this

@article{33ed521c3bee4e4da73f441f03a3854f,

title = "HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead",

author = "{van Molken}, Maureen and Matthijs Versteegh and Bal{\'a}zs Nagy and Sarah Wordsworth",

note = "Funding information: The HEcoPerMed project has received funding from the EU{\textquoteright}s Horizon 2020 research and innovation program under grant agreement No. 824997. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Copyright: 2023 The Authors",

year = "2023",

month = sep,

day = "22",

doi = "10.2217/pme-2022-0074",

language = "English",

volume = "20",

pages = "299--303",

journal = "Personalized Medicine",

issn = "1741-0541",

publisher = "Taylor & Francis Ltd",

number = "4",

}

TY - JOUR

T1 - HEcoPerMed, personalized medicine from a health economic perspective

T2 - lessons learned and potential opportunities ahead

AU - van Molken, Maureen

AU - Versteegh, Matthijs

AU - Nagy, Balázs

AU - Wordsworth, Sarah

N1 - Funding information: The HEcoPerMed project has received funding from the EU’s Horizon 2020 research and innovation program under grant agreement No. 824997. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Copyright: 2023 The Authors

PY - 2023/9/22

Y1 - 2023/9/22

U2 - 10.2217/pme-2022-0074

DO - 10.2217/pme-2022-0074

M3 - Editorial

C2 - 37736874

SN - 1741-0541

VL - 20

SP - 299

EP - 303

JO - Personalized Medicine

JF - Personalized Medicine

IS - 4

ER -